ADXN.SW
Addex Therapeutics Ltd
Price:  
0.06 
CHF
Volume:  
23,088.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ADXN.SW WACC - Weighted Average Cost of Capital

The WACC of Addex Therapeutics Ltd (ADXN.SW) is 4.6%.

The Cost of Equity of Addex Therapeutics Ltd (ADXN.SW) is 4.50%.
The Cost of Debt of Addex Therapeutics Ltd (ADXN.SW) is 7.00%.

Range Selected
Cost of equity 3.70% - 5.30% 4.50%
Tax rate 16.80% - 18.00% 17.40%
Cost of debt 7.00% - 7.00% 7.00%
WACC 3.8% - 5.3% 4.6%
WACC

ADXN.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.35 0.39
Additional risk adjustments 1.0% 1.5%
Cost of equity 3.70% 5.30%
Tax rate 16.80% 18.00%
Debt/Equity ratio 0.05 0.05
Cost of debt 7.00% 7.00%
After-tax WACC 3.8% 5.3%
Selected WACC 4.6%